There are 2934 resources available
Can we be more precise in peri-operative therapy?
Presenter: Michel Ducreux
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
Locally advanced disease: Drugs alone or with the addition of radiotherapy?
Presenter: Stefano Cascinu
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
New targets on the horizon: Integrating genomics with tumour microenvironment
Presenter: Eileen O'Reilly
Session: Pancreatic cancer: Where are we now and where are we going?
Resources:
Slides
Webcast
Introduction: Why differentiation matters
Presenter: Suzanne George
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast
The pathologist's point of view: Methodology to make a difference
Presenter: Hans-Ulrich Schildhaus
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast
Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) - Invited Discussant LBA89, 1736O and 1737O
Presenter: Johan Vansteenkiste
Session: Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC)
Resources:
Slides
Webcast
Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) - Invited Discussant 1738O and 1739O
Presenter: Rafal Dziadziuszko
Session: Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC)
Resources:
Slides
Webcast
1203 - Systemic gut microbial metabolites limit the anti-tumor effect of CTLA-4 blockade in hosts with cancer.
Presenter: Clelia Coutzac
Session: Proffered Paper session - Basic Science
Resources:
Abstract
5576 - Genomic characteristics and predicted ancestry of NTRK1/2/3 and ROS1 fusion-positive tumors from >165,000 pan-solid tumors
Presenter: Timothy R Wilson
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
4536 - Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study)
Presenter: Alexander Drilon
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract